PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HALO vs. HELO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between HALO and HELO is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

HALO vs. HELO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Halozyme Therapeutics, Inc. (HALO) and JPMorgan Hedged Equity Laddered Overlay ETF (HELO). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
1.03%
7.64%
HALO
HELO

Key characteristics

Sharpe Ratio

HALO:

1.56

HELO:

2.33

Sortino Ratio

HALO:

2.11

HELO:

3.22

Omega Ratio

HALO:

1.33

HELO:

1.47

Calmar Ratio

HALO:

1.46

HELO:

4.28

Martin Ratio

HALO:

5.12

HELO:

18.12

Ulcer Index

HALO:

12.34%

HELO:

0.98%

Daily Std Dev

HALO:

40.53%

HELO:

7.66%

Max Drawdown

HALO:

-74.26%

HELO:

-4.16%

Current Drawdown

HALO:

-13.33%

HELO:

-0.77%

Returns By Period

In the year-to-date period, HALO achieves a 16.77% return, which is significantly higher than HELO's 1.56% return.


HALO

YTD

16.77%

1M

16.34%

6M

1.03%

1Y

65.32%

5Y*

24.19%

10Y*

14.65%

HELO

YTD

1.56%

1M

1.37%

6M

7.64%

1Y

17.54%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HALO vs. HELO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HALO
The Risk-Adjusted Performance Rank of HALO is 8585
Overall Rank
The Sharpe Ratio Rank of HALO is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of HALO is 8282
Sortino Ratio Rank
The Omega Ratio Rank of HALO is 8686
Omega Ratio Rank
The Calmar Ratio Rank of HALO is 8686
Calmar Ratio Rank
The Martin Ratio Rank of HALO is 8282
Martin Ratio Rank

HELO
The Risk-Adjusted Performance Rank of HELO is 9292
Overall Rank
The Sharpe Ratio Rank of HELO is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of HELO is 9191
Sortino Ratio Rank
The Omega Ratio Rank of HELO is 9292
Omega Ratio Rank
The Calmar Ratio Rank of HELO is 9393
Calmar Ratio Rank
The Martin Ratio Rank of HELO is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HALO vs. HELO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and JPMorgan Hedged Equity Laddered Overlay ETF (HELO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HALO, currently valued at 1.56, compared to the broader market-2.000.002.001.562.33
The chart of Sortino ratio for HALO, currently valued at 2.11, compared to the broader market-4.00-2.000.002.004.002.113.22
The chart of Omega ratio for HALO, currently valued at 1.33, compared to the broader market0.501.001.502.001.331.47
The chart of Calmar ratio for HALO, currently valued at 1.86, compared to the broader market0.002.004.006.001.864.28
The chart of Martin ratio for HALO, currently valued at 5.12, compared to the broader market0.0010.0020.005.1218.12
HALO
HELO

The current HALO Sharpe Ratio is 1.56, which is lower than the HELO Sharpe Ratio of 2.33. The chart below compares the historical Sharpe Ratios of HALO and HELO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00Oct 06Oct 13Oct 20Oct 27Nov 03Nov 10Nov 17Nov 24DecemberDec 08Dec 15Dec 22Dec 29Jan 05Jan 12Jan 19Jan 26
1.56
2.33
HALO
HELO

Dividends

HALO vs. HELO - Dividend Comparison

HALO has not paid dividends to shareholders, while HELO's dividend yield for the trailing twelve months is around 0.59%.


TTM20242023
HALO
Halozyme Therapeutics, Inc.
0.00%0.00%0.00%
HELO
JPMorgan Hedged Equity Laddered Overlay ETF
0.59%0.60%0.19%

Drawdowns

HALO vs. HELO - Drawdown Comparison

The maximum HALO drawdown since its inception was -74.26%, which is greater than HELO's maximum drawdown of -4.16%. Use the drawdown chart below to compare losses from any high point for HALO and HELO. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-13.33%
-0.77%
HALO
HELO

Volatility

HALO vs. HELO - Volatility Comparison

Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 8.50% compared to JPMorgan Hedged Equity Laddered Overlay ETF (HELO) at 2.71%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than HELO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
8.50%
2.71%
HALO
HELO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab